glp-1 litigation news Lawsuits claiming Ozempic, other GLP-1s led to blindness become second mass over the drugs GLP-1 Receptor Agonists: Drug Litigation
Description
This widespread receptor distribution has prompted investigation into potential pleiotropic effects, including anti-inflammatory properties that may contribute to their broader clinical benefits in cardiometabolic disease
Your journey is so incredible
To learn more about Lilly Canada, please visit us at www.lilly.ca
We will review your lab results, discuss your goals, and select the most suitable medication for your individual needs
